Relief Cardiovascular

Pre-clinical

Santa Clara, United StatesFounded 2022reliefcardio.com

Established in 2022, privately-owned Relief Cardiovascular’s mission is to reduce the burden associated with congestive heart failure. The Company is focused on the development of transcatheter smart implant systems to enhance volume management in heart failure. Its first-generation Relief System for inferior vena cava flow modulation started its OUS clinical investigation in September 2025.

Founded

2022

Focus

CardiovascularMedical Devices

About

Established in 2022, privately-owned Relief Cardiovascular’s mission is to reduce the burden associated with congestive heart failure. The Company is focused on the development of transcatheter smart implant systems to enhance volume management in heart failure. Its first-generation Relief System for inferior vena cava flow modulation started its OUS clinical investigation in September 2025.

Funding History

1

Total raised: $5M

Seed$5MUndisclosedJun 15, 2022

Company Info

TypePrivate

Founded2022

LocationSanta Clara, United States

StagePre-clinical

Contact

reliefcardio.com

Sectors

Drug Delivery & Formulation

SIMILAR COMPANIES

BASi Research Products

Pre-clinical · West Lafayette

Bay BioSciences

Pre-clinical · San Francisco

Pre-clinical · Cambridge

Pre-clinical · Memphis

Belcher Pharmaceuticals

Pre-clinical · Miami

Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.